Published by Benjamin Chiou on 5th January 2026
(Sharecast News) - Pharma giant GSK has received regulatory approval in China for its Nucala treatment for adults with inadequately controlled chronic obstructive pulmonary disease (COPD).
URL: http://www.digitallook.com/dl/news/story/35606947/...